---
document_datetime: 2025-07-17 10:08:14
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/skyrizi-epar-all-authorised-presentations_en.pdf
document_name: skyrizi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4541044
conversion_datetime: 2025-12-18 11:40:32.190292
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form                   | Route of administration   | Immediate Packaging             | Content (concentration)   | Pack size                              |
|------------------|-------------------|------------|---------------------------------------|---------------------------|---------------------------------|---------------------------|----------------------------------------|
| EU/1/19/1361/001 | Skyrizi           | 75 mg      | Solution for injection                | Subcutaneous use          | Pre-filled syringe (glass)      | 0.83 ml (75 mg/0.83 ml)   | 2 pre-filled syringes + 2 alcohol pads |
| EU/1/19/1361/002 | Skyrizi           | 150 mg     | Solution for injection                | Subcutaneous use          | Pre-filled pen (glass)          | 1 ml (150 mg/ml)          | 1 pre-filled pen                       |
| EU/1/19/1361/003 | Skyrizi           | 150 mg     | Solution for injection                | Subcutaneous use          | Pre-filled syringe (glass)      | 1 ml (150 mg/ml)          | 1 pre-filled syringe                   |
| EU/1/19/1361/004 | Skyrizi           | 600 mg     | Concentrate for solution for infusion | Intravenous use           | Vial (glass)                    | 10 ml (60 mg/ml)          | 1 vial                                 |
| EU/1/19/1361/005 | Skyrizi           | 360 mg     | Solution for injection                | Subcutaneous use          | Cartridge (cyclic olefin resin) | 2.4 ml (150 mg/ml)        | 1 cartridge + 1 on-body injector       |
| EU/1/19/1361/006 | Skyrizi           | 90 mg      | Solution for injection                | Subcutaneous use          | Pre-filled syringe (glass)      | 1 ml (90 mg/ml)           | 4 pre-filled syringes                  |
| EU/1/19/1361/007 | Skyrizi           | 180 mg     | Solution for injection                | Subcutaneous use          | Cartridge (cyclic olefin resin) | 1.2 ml (150 mg/ml)        | 1 cartridge + 1 on-body injector       |
| EU/1/19/1361/008 | Skyrizi           | 180 mg     | Solution for injection                | Subcutaneous use          | Pre-filled syringe (glass)      | 1.2 ml (150 mg/ml)        | 1 pre-filled syringe                   |
| EU/1/19/1361/009 | Skyrizi           | 180 mg     | Solution for injection                | Subcutaneous use          | Pre-filled syringe (glass)      | 1.2 ml (150 mg/ml)        | 2 pre-filled syringes                  |